EC
NMR icon

Elequin Capital’s Nomura Holdings NMR Stock Holding History

Elequin Capital’s Portfolio NMR Stock Details NMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.83K Buy
+865
New +$7.45K ﹤0.01% 364

Other funds holding NMR

DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Elequin Capital's NMR Position: Q1 2026 in Review

Elequin Capital opened a new position in Nomura Holdings (NMR) in Q1 2026: 865 shares worth $6.83K. The stake represents ﹤0.01% of the portfolio and ranks #364 among its holdings.

271 funds tracked by Wall St. Rank hold NMR as of Q1 2026.

  • Elequin Capital held 865 shares of Nomura Holdings worth $6.83K as of Q1 2026.
  • Nomura Holdings was a new Elequin Capital position in Q1 2026.
  • Nomura Holdings made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #364 holding.
  • 271 funds tracked by Wall St. Rank held Nomura Holdings as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.